Hvilke konsekvenser har afslaget for patienter, der deltager i kliniske undersøgelser / programmer for specialudlevering af Valdoxan/ Thymanax?
What are the consequences of the refusal for patients undergoing clinical trials/ compassionate use programmes with Valdoxan/ Thymanax?